AXIM Axim Biotechnologies Inc

Price (delayed)

$0.68

Market cap

$87.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.06

Enterprise value

$93.48M

Highlights
AXIM's EPS is up by 40% YoY and by 14% QoQ
Axim Biotechnologies's equity has soared by 123% YoY but it has decreased by 32% from the previous quarter
The company's quick ratio has shrunk by 61% QoQ but it rose by 48% YoY
The company's revenue has shrunk by 100% QoQ
The gross profit has dropped by 100% since the previous quarter

Key stats

What are the main financial stats of AXIM
Market
Shares outstanding
128.86M
Market cap
$87.62M
Enterprise value
$93.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
54.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$6.18M
EBITDA
-$6.16M
Free cash flow
-$3.31M
Per share
EPS
-$0.06
Free cash flow per share
-$0.03
Book value per share
$0.01
Revenue per share
$0
TBVPS
$0.08
Balance sheet
Total assets
$11.31M
Total liabilities
$9.75M
Debt
$6.31M
Equity
$1.57M
Working capital
-$783,163
Liquidity
Debt to equity
4.03
Current ratio
0.48
Quick ratio
0.31
Net debt/EBITDA
-0.95
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-56.4%
Return on equity
-570.9%
Return on invested capital
-56%
Return on capital employed
-62.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXIM stock price

How has the Axim Biotechnologies stock price performed over time
Intraday
6.25%
1 week
-9.93%
1 month
-25.07%
1 year
-3.95%
YTD
57.12%
QTD
-27.58%

Financial performance

How have Axim Biotechnologies's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$4.95M
Net income
-$6.41M
Gross margin
N/A
Net margin
N/A
The company's revenue has shrunk by 100% QoQ
The gross profit has dropped by 100% since the previous quarter
The company's operating income has shrunk by 59% YoY and by 13% QoQ
AXIM's net income is down by 18% since the previous quarter

Growth

What is Axim Biotechnologies's growth rate over time

Valuation

What is Axim Biotechnologies stock price valuation
P/E
N/A
P/B
54.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
AXIM's EPS is up by 40% YoY and by 14% QoQ
Axim Biotechnologies's equity has soared by 123% YoY but it has decreased by 32% from the previous quarter
The company's revenue has shrunk by 100% QoQ

Efficiency

How efficient is Axim Biotechnologies business performance
The ROA has soared by 78% YoY and by 7% from the previous quarter
Axim Biotechnologies's ROIC has soared by 74% YoY and by 9% from the previous quarter

Dividends

What is AXIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXIM.

Financial health

How did Axim Biotechnologies financials performed over time
Axim Biotechnologies's total assets is 16% more than its total liabilities
The company's quick ratio has shrunk by 61% QoQ but it rose by 48% YoY
Axim Biotechnologies's current ratio has plunged by 52% from the previous quarter
Axim Biotechnologies's equity has soared by 123% YoY but it has decreased by 32% from the previous quarter
Axim Biotechnologies's debt to equity has increased by 48% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.